about
sameAs
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisAntibody to aquaporin 4 in the diagnosis of neuromyelitis opticaNeurodegeneration in multiple sclerosis: novel treatment strategiesMultiple sclerosis in 2012: Novel therapeutic options and drug targets in MSGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisParallelized TCSPC for dynamic intravital fluorescence lifetime imaging: quantifying neuronal dysfunction in neuroinflammationLack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brainActivation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous systemMitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosisMetabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic ImagingGenome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.Understanding the Role of T Cells in CNS Homeostasis.MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4.A human post-mortem brain model for the standardization of multi-centre MRI studies.Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.High-field diffusion tensor imaging of mouse brain in vivo using single-shot STEAM MRI.The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple SclerosisA new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.Expanding two-photon intravital microscopy to the infrared by means of optical parametric oscillator.Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study.Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.MRI pattern recognition in multiple sclerosis normal-appearing brain areas.In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity.Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.Two laboratory-confirmed cases of Japanese encephalitis imported to Germany by travelers returning from Southeast Asia.Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.Two-photon imaging of immune cells in neural tissue.Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis.Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosisRegulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis therapy.Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model.FRET based ratiometric Ca(2+) imaging to investigate immune-mediated neuronal and axonal damage processes in experimental autoimmune encephalomyelitis.Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravityIncidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
P50
Q21144329-E376DB70-1FF5-4DA0-931D-634D2076C41AQ21144670-9FA1A625-E8B4-4F07-82A1-4337AC90535EQ22241472-928FFC73-AD39-4504-AE35-21C67E76969FQ22251014-3C65A9D4-8DB8-47DE-B54D-B415A13864C0Q24635370-F9202B7C-A2AF-4685-8B52-C78B5A89E957Q27332028-206F97B7-B3CA-49A2-A1D2-F71EDBD48484Q28201285-F8748DE1-62B8-409B-AADE-21417BD41845Q28250134-48575122-FF90-4D74-A1E9-B2EF27C0AC58Q28480940-F4FDE645-CB7B-4270-B233-A6D6E9BDD692Q29308070-BC765D79-A516-4CED-B6CF-2A40BC642C03Q29417047-DF4DF870-3BEC-41A2-8200-53F25AD4CA67Q29417106-652F4C7E-5168-41B7-BD8B-7227E987DC45Q30277739-19D0476E-CF9B-4150-9705-ACBCA03738A9Q30405378-B3EE5107-4003-4257-BCC0-64AC6DEC1C6CQ30884747-0C39E06E-3ECD-48F3-8F37-6D708B2E8A47Q30928115-21310A1A-A96D-4A9D-A137-3C7045F4B122Q31009955-66AEA96F-3C2C-4D33-B318-3CCD26E98482Q31085978-9135F6D0-7580-4481-ACE8-267A28FB2013Q31121073-18DB93CC-776D-4441-B191-63EA79131C6BQ33526913-34E44D85-24AB-4CAB-AC87-DC50C0F727BDQ33531586-78923D1B-0786-42A5-BA9B-5DDC96856DE4Q33547267-07AAA105-F225-41B7-A45B-618A7EA63843Q33774221-0A5E0CF7-19F7-40A3-9015-240C690F3B97Q33939194-1EBF67F2-A163-4368-8FFF-F152461FA355Q34042100-9867C301-65C6-477C-8889-6D862031C77BQ34055604-4CCF073F-5EFD-4C22-9F2A-A073A18EE86BQ34098754-152DDE58-674A-4A59-93F7-3F19CEF13E30Q34215660-95212520-461A-4931-A926-23A3AC85DF37Q34474046-FE2C3D67-FE56-4C0A-8848-60177BD9DB24Q34535269-66FA2EE8-CB20-4520-9A3E-B2FE23669B46Q34606195-FDAAEB31-9EC7-49E0-8F10-5FB748EF2E44Q34649942-6F6C6435-3806-4785-BE73-432C0BDB8977Q34988315-B0B56018-A150-49D9-9879-24AF15E88C65Q35025511-58836177-95B8-445C-9B75-851097F7C9E9Q35061370-DA8791F4-B275-4827-8508-D2382E069D2FQ35205220-123E0BB9-6DC1-4EC6-AE85-FC083B486807Q35208300-0E4F2788-0A47-42DF-936A-C4E00E6BB54FQ35599751-077E7B9E-DF81-41D3-9C0C-00CD5200AC9AQ35744925-C03F0973-2FDD-4CE4-8294-4812FDB2DCA1Q35825923-8101C5A2-2F0A-4947-B5F2-AC6E5E389C58
P50
description
deutsche Neurologin und Hochschullehrerin
@de
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Frauke Zipp
@ast
Frauke Zipp
@de
Frauke Zipp
@en
Frauke Zipp
@es
Frauke Zipp
@nl
Frauke Zipp
@sl
type
label
Frauke Zipp
@ast
Frauke Zipp
@de
Frauke Zipp
@en
Frauke Zipp
@es
Frauke Zipp
@nl
Frauke Zipp
@sl
prefLabel
Frauke Zipp
@ast
Frauke Zipp
@de
Frauke Zipp
@en
Frauke Zipp
@es
Frauke Zipp
@nl
Frauke Zipp
@sl
P214
P227
P1053
C-9968-2015
P106
P2080
P21
P214
P227
1033683590
P2456
P31
P3829
P496
0000-0002-1231-1928
P5463
Zipp_Frauke
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-300036063